Substance use and mental health outcomes for comorbid patients in psychiatric day treatment

Stephen Magura, Andrew Rosenblum, Thomas F. Betzler

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The study's purpose was to determine treatment outcomes for patients who present with drug use vs. those presenting with no drug use at admission to a psychiatric day treatment program. Consecutively admitted patients completed confidential interviews which included psychological distress and quality of life measures and provided urine specimens for toxicology at admission and six month follow-up. Subjects positive by past 30 day self-report or urinalysis were categorized as drug users. Major psychiatric diagnoses were: major depression 25%; bipolar, 13%; other mood 13%; schizoaffective 13%; schizophrenia 13%. Drug use at admission was: cocaine 35%; marijuana 33%; opiates 18%, (meth)amphetamines, 6% For each of these drugs, the percentage of patients positive at admission who remitted from using the drug significantly exceeded the percentage negative at baseline who initiated using the drug. Overall, there were significant decreases in psychological distress and significant improvement on quality of life, but no change on positive affect. There were no significant differences between drug users and non-drug users on symptom reduction and improvement in quality of life. Psychiatric day treatment appears to benefit comorbid patients by reducing the net number of patients who actively use certain common drugs and by improving psychological status and quality of life to the same degree as for non-drug using patients.

Original languageEnglish (US)
Pages (from-to)71-78
Number of pages8
JournalSubstance Abuse: Research and Treatment
Volume3
Issue number1
StatePublished - 2009

Fingerprint

Psychiatry
Mental Health
Pharmaceutical Preparations
Quality of Life
Psychology
Drug Users
Therapeutics
Opiate Alkaloids
Amphetamines
Urinalysis
Cannabis
Cocaine
Mental Disorders
Toxicology
Self Report
Schizophrenia
Urine
Interviews
Depression

Keywords

  • Co-occurring disorders
  • Comorbidity
  • Psychiatric treatment
  • Substance abuse
  • Treatment outcomes

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Substance use and mental health outcomes for comorbid patients in psychiatric day treatment. / Magura, Stephen; Rosenblum, Andrew; Betzler, Thomas F.

In: Substance Abuse: Research and Treatment, Vol. 3, No. 1, 2009, p. 71-78.

Research output: Contribution to journalArticle

@article{00eeb6db758443d6b096c02b9a35b260,
title = "Substance use and mental health outcomes for comorbid patients in psychiatric day treatment",
abstract = "The study's purpose was to determine treatment outcomes for patients who present with drug use vs. those presenting with no drug use at admission to a psychiatric day treatment program. Consecutively admitted patients completed confidential interviews which included psychological distress and quality of life measures and provided urine specimens for toxicology at admission and six month follow-up. Subjects positive by past 30 day self-report or urinalysis were categorized as drug users. Major psychiatric diagnoses were: major depression 25{\%}; bipolar, 13{\%}; other mood 13{\%}; schizoaffective 13{\%}; schizophrenia 13{\%}. Drug use at admission was: cocaine 35{\%}; marijuana 33{\%}; opiates 18{\%}, (meth)amphetamines, 6{\%} For each of these drugs, the percentage of patients positive at admission who remitted from using the drug significantly exceeded the percentage negative at baseline who initiated using the drug. Overall, there were significant decreases in psychological distress and significant improvement on quality of life, but no change on positive affect. There were no significant differences between drug users and non-drug users on symptom reduction and improvement in quality of life. Psychiatric day treatment appears to benefit comorbid patients by reducing the net number of patients who actively use certain common drugs and by improving psychological status and quality of life to the same degree as for non-drug using patients.",
keywords = "Co-occurring disorders, Comorbidity, Psychiatric treatment, Substance abuse, Treatment outcomes",
author = "Stephen Magura and Andrew Rosenblum and Betzler, {Thomas F.}",
year = "2009",
language = "English (US)",
volume = "3",
pages = "71--78",
journal = "Substance Abuse: Research and Treatment",
issn = "1178-2218",
publisher = "Libertas Academica Ltd.",
number = "1",

}

TY - JOUR

T1 - Substance use and mental health outcomes for comorbid patients in psychiatric day treatment

AU - Magura, Stephen

AU - Rosenblum, Andrew

AU - Betzler, Thomas F.

PY - 2009

Y1 - 2009

N2 - The study's purpose was to determine treatment outcomes for patients who present with drug use vs. those presenting with no drug use at admission to a psychiatric day treatment program. Consecutively admitted patients completed confidential interviews which included psychological distress and quality of life measures and provided urine specimens for toxicology at admission and six month follow-up. Subjects positive by past 30 day self-report or urinalysis were categorized as drug users. Major psychiatric diagnoses were: major depression 25%; bipolar, 13%; other mood 13%; schizoaffective 13%; schizophrenia 13%. Drug use at admission was: cocaine 35%; marijuana 33%; opiates 18%, (meth)amphetamines, 6% For each of these drugs, the percentage of patients positive at admission who remitted from using the drug significantly exceeded the percentage negative at baseline who initiated using the drug. Overall, there were significant decreases in psychological distress and significant improvement on quality of life, but no change on positive affect. There were no significant differences between drug users and non-drug users on symptom reduction and improvement in quality of life. Psychiatric day treatment appears to benefit comorbid patients by reducing the net number of patients who actively use certain common drugs and by improving psychological status and quality of life to the same degree as for non-drug using patients.

AB - The study's purpose was to determine treatment outcomes for patients who present with drug use vs. those presenting with no drug use at admission to a psychiatric day treatment program. Consecutively admitted patients completed confidential interviews which included psychological distress and quality of life measures and provided urine specimens for toxicology at admission and six month follow-up. Subjects positive by past 30 day self-report or urinalysis were categorized as drug users. Major psychiatric diagnoses were: major depression 25%; bipolar, 13%; other mood 13%; schizoaffective 13%; schizophrenia 13%. Drug use at admission was: cocaine 35%; marijuana 33%; opiates 18%, (meth)amphetamines, 6% For each of these drugs, the percentage of patients positive at admission who remitted from using the drug significantly exceeded the percentage negative at baseline who initiated using the drug. Overall, there were significant decreases in psychological distress and significant improvement on quality of life, but no change on positive affect. There were no significant differences between drug users and non-drug users on symptom reduction and improvement in quality of life. Psychiatric day treatment appears to benefit comorbid patients by reducing the net number of patients who actively use certain common drugs and by improving psychological status and quality of life to the same degree as for non-drug using patients.

KW - Co-occurring disorders

KW - Comorbidity

KW - Psychiatric treatment

KW - Substance abuse

KW - Treatment outcomes

UR - http://www.scopus.com/inward/record.url?scp=77956465086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956465086&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:77956465086

VL - 3

SP - 71

EP - 78

JO - Substance Abuse: Research and Treatment

JF - Substance Abuse: Research and Treatment

SN - 1178-2218

IS - 1

ER -